Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arav

Showing results (201-210 of 236) with videos related to

Pageof 24
Sort By:
Journal of Virology|March 20, 2023
Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus ControlAyan K Ghosh, Yu-Pin Su, Michael Forman, et al.
The Journal of Biological Chemistry|August 29, 2020
Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibitionSujayita Roy, Arun Kapoor, Fei Zhu, et al.
The Journal of Infectious Diseases|July 18, 2006
Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infectionRavit Arav-Boger, Catherine A Battaglia, Tiziana Lazzarotto, et al.
Tissue Engineering. Part B, Reviews|February 11, 2010
Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measuresGadi Pelled, Ayelet Ben-Arav, Colleen Hock, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Digitoxin analogues with improved anticytomegalovirus activityHongyi Cai, Hua-Yu L Wang, Rajkumar Venkatadri, et al.
Msphere|February 15, 2019
Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of <i>In Vitro</i> ScreeningsJoseph W Jackson, Trevor J Hancock, Pranay Dogra, et al.
Open Forum Infectious Diseases|July 9, 2019
Prevalence, Magnitude, and Genotype Distribution of Urinary Cytomegalovirus (CMV) Shedding Among CMV-Seropositive Children and Adolescents in the United StatesJodie L White, Eshan U Patel, Alison G Abraham, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2018
Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic OzonidesYiping Wang, Rupkatha Mukhopadhyay, Sujayita Roy, et al.
Iscience|January 15, 2025
ZFAND6 promotes TRAF2-dependent mitophagy to restrain cGAS-STING signalingKashif Shaikh, Melissa Bowman, Sarah M McCormick, et al.
Viruses|March 27, 2025
Interspecies Differences in Cytomegalovirus Inhibition by Cardiac Glycosides-A Unique Role of the Alpha3 Isoform of the Na<sup>+</sup>/K<sup>+</sup>-ATPase PumpHong Mei, Hongyi Cai, Fengjie Liu, et al.
Pageof 24

Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
Journal of Virology|March 20, 2023
Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus ControlAyan K Ghosh, Yu-Pin Su, Michael Forman, et al.
The Journal of Biological Chemistry|August 29, 2020
Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibitionSujayita Roy, Arun Kapoor, Fei Zhu, et al.
The Journal of Infectious Diseases|July 18, 2006
Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infectionRavit Arav-Boger, Catherine A Battaglia, Tiziana Lazzarotto, et al.
Tissue Engineering. Part B, Reviews|February 11, 2010
Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measuresGadi Pelled, Ayelet Ben-Arav, Colleen Hock, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Digitoxin analogues with improved anticytomegalovirus activityHongyi Cai, Hua-Yu L Wang, Rajkumar Venkatadri, et al.
Msphere|February 15, 2019
Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of <i>In Vitro</i> ScreeningsJoseph W Jackson, Trevor J Hancock, Pranay Dogra, et al.
Open Forum Infectious Diseases|July 9, 2019
Prevalence, Magnitude, and Genotype Distribution of Urinary Cytomegalovirus (CMV) Shedding Among CMV-Seropositive Children and Adolescents in the United StatesJodie L White, Eshan U Patel, Alison G Abraham, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2018
Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic OzonidesYiping Wang, Rupkatha Mukhopadhyay, Sujayita Roy, et al.
Iscience|January 15, 2025
ZFAND6 promotes TRAF2-dependent mitophagy to restrain cGAS-STING signalingKashif Shaikh, Melissa Bowman, Sarah M McCormick, et al.
Viruses|March 27, 2025
Interspecies Differences in Cytomegalovirus Inhibition by Cardiac Glycosides-A Unique Role of the Alpha3 Isoform of the Na<sup>+</sup>/K<sup>+</sup>-ATPase PumpHong Mei, Hongyi Cai, Fengjie Liu, et al.
Pageof 24